Search results
Madrigal Pharmaceuticals (NASDAQ:MDGL) Shares Gap Down to $244.35
ETF DAILY NEWS· 1 day agoMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report)’s stock price gapped down prior to trading on Wednesday . Madrigal Pharmaceuticals shares ...
Justin Liby on Pharmaceutical Industry | JD Supra
JD Supra· 2 days agoJD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations. This Privacy Policy describes how JD Supra ...
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $20.25 Consensus Target Price from Brokerages
ETF DAILY NEWS· 1 day agoFusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) has been assigned a consensus rating of...
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded to Buy by Jefferies Financial Group
ETF DAILY NEWS· 1 day agoCollegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a report released ...
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong Financials Guiding The...
Simply Wall St. via Yahoo Finance· 20 hours agoMost readers would already know that Catalyst Pharmaceuticals' (NASDAQ:CPRX) stock increased by 4.1%...
Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim
Motley Fool via Yahoo Finance· 22 hours agoOne stock that is your typical high-risk, high-potential-reward option is Recursion Pharmaceuticals...
Collegium Pharmaceutical stock upgraded from Hold to Buy By Investing.com
Investing.com· 23 hours agoOn Friday, Collegium Pharmaceutical Inc. (NASDAQ:COLL) received an upgrade from Jefferies from Hold...
All You Need to Know About ASLAN Pharmaceuticals (ASLN) Rating Upgrade to Buy
Zacks via Yahoo Finance· 4 days agoASLAN Pharmaceuticals (ASLN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism...
Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders have endured a 76% loss from investing in the stock...
Simply Wall St. via Yahoo Finance· 2 days agoAs every investor would know, not every swing hits the sweet spot. But you want to avoid the really...
Cycle Pharmaceuticals offers to acquire Vanda Pharma for $466m
Pharmaceutical Technology via Yahoo Finance· 1 day agoCycle Pharmaceuticals has proposed to acquire all issued and outstanding shares of Vanda ...